BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11523023)

  • 1. The negative impact of anemia on radiotherapy and chemoradiation outcomes.
    Shasha D
    Semin Hematol; 2001 Jul; 38(3 Suppl 7):8-15. PubMed ID: 11523023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapy.
    Dunst J
    Semin Oncol; 2001 Apr; 28(2 Suppl 8):42-8. PubMed ID: 11395852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment.
    Harrison LB; Shasha D; Homel P
    Oncology; 2002; 63 Suppl 2():11-8. PubMed ID: 12466640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tumor hypoxia and anemia on radiation therapy outcomes.
    Harrison LB; Chadha M; Hill RJ; Hu K; Shasha D
    Oncologist; 2002; 7(6):492-508. PubMed ID: 12490737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia, tumor hypoxemia, and the cancer patient.
    Varlotto J; Stevenson MA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia treatment and the radiation oncologist: optimizing patient outcomes.
    Shasha D; Harrison LB
    Oncology (Williston Park); 2001 Nov; 15(11):1486-91; discussion 1494-6. PubMed ID: 11758875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing?
    Dunst J
    Strahlenther Onkol; 2004 Nov; 180(11):671-81. PubMed ID: 15549184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rHuEPO and treatment outcomes: the clinical experience.
    Hudis CA; Van Belle S; Chang J; Muenstedt K
    Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer therapy. New strategies and treatment modalities for optimizing patient outcomes.
    Gabrilove JL
    Semin Hematol; 2001 Jul; 38(3 Suppl 7):1-7. PubMed ID: 11523022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
    Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rHuEPO and treatment outcomes: the preclinical experience.
    Ludwig H
    Oncologist; 2004; 9 Suppl 5():48-54. PubMed ID: 15591422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor hypoxia and anemia: impact on the efficacy of radiation therapy.
    Kumar P
    Semin Hematol; 2000 Oct; 37(4 Suppl 6):4-8. PubMed ID: 11068949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hemoglobin levels and quality of life during radiation therapy plus concomitant or sequential chemotherapy in patients with cancer and anemia treated with epoetin alfa.
    Shasha D; Cremieux P; Harrison L
    J Natl Compr Canc Netw; 2004 Sep; 2(5):509-17. PubMed ID: 19780258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of anemia in patients with head and neck cancer.
    Kumar P
    Oncologist; 2000; 5 Suppl 2():13-8. PubMed ID: 10896324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
    Cortesi E; Mancuso A; De Pasquale Ceratti A; Pizzardi N; D'Auria G; Accettura C; Beccaglia P; Bertelletti D; De Marinis F
    Oncologist; 2004; 9(4):459-68. PubMed ID: 15266099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
    Stovall TG
    J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rHuEPO and improved treatment outcomes: potential modes of action.
    Blackwell K; Gascón P; Sigounas G; Jolliffe L
    Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D; George MJ; Harrison LB
    Cancer; 2003 Sep; 98(5):1072-9. PubMed ID: 12942577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.